Table 3.

Long-Term Outcomes of 11 Patients Without Successful Ablation

			1 year after RAI			Last follow-up
No.	Age/sex	RAI dose(GBq)	sTg	TgAb	US	sTg	TgAb	Clinical recurrence	Biochemical recurrence
1	50/F	1.1	<1	pos	neg	<1	pos	(–)	(+)
2	69/F	1.1	<1	pos	neg	<1	neg	(–)	(–)
3	52/F	1.1	1.8	neg	neg	<1	neg	(–)	(–)
4	28/F	5.5	1.3	neg	neg	1.7	neg	(–)	(+)
5	39/F	5.5	<1	pos	neg	<1	pos	(–)	(+)
6	42/F	5.5	<1	pos	neg	<1	neg	(–)	(–)
7	52/F	5.5	1.3	neg	neg	<1	neg	(–)	(–)
8	55/F	5.5	1.3	neg	neg	<1	neg	(–)	(–)
9	47/F	5.5	2.3	neg	neg	<1	neg	(–)	(–)
10	52/F	5.5	1.6	neg	neg	<1	neg	(–)	(–)
11	44/F	5.5	<1	neg	pos	<1	neg	(–)	(–)

Negative TgAb, TgAb <60 U/mL; US, ultrasonography.